These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6884214)

  • 21. Pulmonary arterial pressure and working capacity as parameters for checking the development of tolerance under nitrate therapy.
    Tauchert M; Jansen W
    Z Kardiol; 1990; 79 Suppl 3():67-77. PubMed ID: 2099043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronotherapy in coronary heart disease: comparison of two nitrate treatments.
    Wortmann A; Bachmann K
    Chronobiol Int; 1991; 8(5):399-408. PubMed ID: 1818788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemodynamic and electrocardiographic prolonged nitrate effect during frequency load in coronary disease].
    Wolf R; Beck OA; Guhl E; Hochrein H
    Z Kardiol; 1976 May; 65(5):435-44. PubMed ID: 820104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology.
    Rabinowitz B; Katz A; Shotan A; Chouraqui P; Neufeld HN
    Eur Heart J; 1988 Jan; 9 Suppl A():175-80. PubMed ID: 3409914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Continuing anti-anginal effectiveness during chronic nitrate therapy in spite of the cessation of hemodynamic partial effects].
    Kaltenbach M; Schneider W
    Dtsch Med Wochenschr; 1986 Mar; 111(10):383-6. PubMed ID: 3512226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian investigation of interval therapy with isosorbide dinitrate in coronary heart disease.
    Wortmann A; Bachmann K; Meinhold M
    Eur Heart J; 1988 Jan; 9 Suppl A():119-24. PubMed ID: 3409908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
    Jansen W; Osterspey A; Fuchs M; Tauchert M; Schell U; Weste S; Hombach V
    Med Welt; 1982 Dec; 33(48):1756-62. PubMed ID: 6818416
    [No Abstract]   [Full Text] [Related]  

  • 30. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
    Tsai YT; Lee FY; Lin HC; Chang TT; Lay CS; Wang SS; Kong CW; Lee SD; Lo KJ
    Hepatology; 1989 Sep; 10(3):283-7. PubMed ID: 2759546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute effects of isosorbide mononitrate on blood circulation and myocardial ischemia in patients with coronary atherosclerosis].
    Manfroi WC; Zago AJ; Ribeiro JP; Raudales JC; Fanti L; Brum EM; Perin A; Oliveira J
    Arq Bras Cardiol; 1995 Jul; 65(1):11-5. PubMed ID: 8546588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
    Isbary J; Doering W; Wauer B; Greding H; König E
    Med Welt; 1981 Apr; 32(14A):530-4. PubMed ID: 7242315
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemodynamic action of isosorbide-5-mononitrate during rapid venous administration in patients with acute myocardial infarct].
    Daskalov T
    Vutr Boles; 1988; 27(2):26-33. PubMed ID: 3414098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Z Kardiol; 1983; 72 Suppl 3():173-7. PubMed ID: 6666218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction.
    Gammage MD; Murray RG; Littler WA
    Eur J Clin Pharmacol; 1986; 29(6):639-43. PubMed ID: 3709607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodynamic study of the development of tolerance in intravenous nitrate therapy].
    Unverdorben M; Pfeiffer F; Kunkel B; Bachmann K
    Z Kardiol; 1989; 78 Suppl 2():88-94; discussion 115-7. PubMed ID: 2686259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echo-dipyridamole stress test evaluation of isosorbide-5-mononitrate efficacy and tolerance in patients with coronary heart disease: interplay with sympathetic activity.
    Longobardi G; Ferrara N; Leosco D; Abete P; Iannuzzi GL; Acanfora D; Furgi G; Nicolino A; Pinna G; Rengo F
    J Cardiovasc Pharmacol; 2000 Jul; 36(1):50-5. PubMed ID: 10892660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of lisinopril and isosorbide-5-mononitrate on hemodynamics and mortality in rats with permanent coronary artery occlusion.
    Riva E; Kurosaki M; Latini R
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):490-5. PubMed ID: 1279297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of the development of tolerance to isosorbide dinitrate in interval therapy].
    Blasini R; Reiniger G; Brügmann U; Rudolph W
    Herz; 1984 Jun; 9(3):166-70. PubMed ID: 6378743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of the delayed-action form of isosorbide 5-mononitrate in ischemic heart disease].
    Hůla J; Trhlíková M
    Vnitr Lek; 1991 Mar; 37(3):248-54. PubMed ID: 2031313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.